- Home
- L vs BAX Comparison
L vs BAX Comparison
Compare L & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- L
- BAX
- Stock Information
- Founded
- L 1969
- BAX 1931
- Country
- L United States
- BAX United States
- Employees
- L N/A
- BAX N/A
- Industry
- L Property-Casualty Insurers
- BAX Medical/Dental Instruments
- Sector
- L Finance
- BAX Health Care
- Exchange
- L Nasdaq
- BAX Nasdaq
- Market Cap
- L 18.5B
- BAX 15.7B
- IPO Year
- L N/A
- BAX N/A
- Fundamental
- Price
- L $91.33
- BAX $31.11
- Analyst Decision
- L
- BAX Buy
- Analyst Count
- L 0
- BAX 8
- Target Price
- L N/A
- BAX $37.25
- AVG Volume (30 Days)
- L 899.6K
- BAX 3.4M
- Earning Date
- L 07-28-2025
- BAX 08-05-2025
- Dividend Yield
- L 0.27%
- BAX 2.18%
- EPS Growth
- L N/A
- BAX N/A
- EPS
- L 6.09
- BAX N/A
- Revenue
- L $17,773,000,000.00
- BAX $10,771,000,000.00
- Revenue This Year
- L N/A
- BAX $8.05
- Revenue Next Year
- L N/A
- BAX $4.19
- P/E Ratio
- L $15.17
- BAX N/A
- Revenue Growth
- L 8.71
- BAX 15.36
- 52 Week Low
- L $73.15
- BAX $26.25
- 52 Week High
- L $92.49
- BAX $40.49
- Technical
- Relative Strength Index (RSI)
- L 59.60
- BAX 55.58
- Support Level
- L $88.76
- BAX $30.06
- Resistance Level
- L $92.49
- BAX $31.76
- Average True Range (ATR)
- L 1.27
- BAX 0.68
- MACD
- L 0.26
- BAX 0.08
- Stochastic Oscillator
- L 75.11
- BAX 73.36
About L Loews Corporation
Loews Corp is a holding company along with its subsidiary engaged in commercial property and casualty insurance, transportation and storage of natural gas and natural gas liquids, operation of a chain of hotels, and also in the manufacture of rigid plastic packaging solutions. It has four reportable segments comprised of three individual consolidated operating subsidiaries, CNA Financial Corporation, Boardwalk Pipeline Partners, LP and Loews Hotels Holding Corporation; and the Corporate segment.
About BAX Baxter International Inc.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.